Dr. Reddy's Laboratories (RDY) News Today $13.82 +0.22 (+1.58%) Closing price 08/8/2025 03:59 PM EasternExtended Trading$13.80 -0.01 (-0.07%) As of 08/8/2025 06:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RDY Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period XY Capital Ltd Sells 47,520 Shares of Dr. Reddy's Laboratories Ltd (NYSE:RDY)5 hours ago | marketbeat.comUS Bancorp DE Has $2.15 Million Holdings in Dr. Reddy's Laboratories Ltd (NYSE:RDY)August 9 at 3:47 AM | marketbeat.comPinpoint Asset Management Ltd Reduces Position in Dr. Reddy's Laboratories Ltd (NYSE:RDY)August 8 at 7:56 AM | marketbeat.comEnvestnet Asset Management Inc. Cuts Stock Holdings in Dr. Reddy's Laboratories Ltd (NYSE:RDY)August 7 at 3:05 AM | marketbeat.comDr. Reddy's: Needs To Invest $0.95 To Produce $1 Of New RevenuesAugust 4, 2025 | seekingalpha.comComparing Dr. Reddy's Laboratories (NYSE:RDY) and Acura Pharmaceuticals (OTCMKTS:ACUR)August 2, 2025 | americanbankingnews.comDr. Reddy's Laboratories Ltd (NYSE:RDY) Shares Sold by Allianz Asset Management GmbHJuly 29, 2025 | marketbeat.comDr. Reddy’s Laboratories Releases Q1 2025 Earnings Call AudioJuly 25, 2025 | theglobeandmail.comDr. Reddy's Laboratories Limited (RDY) Q1 2026 Earnings Call TranscriptJuly 23, 2025 | seekingalpha.comDr. Reddy's Laboratories Limited 2026 Q1 - Results - Earnings Call PresentationJuly 23, 2025 | seekingalpha.comDr. Reddy's Q1FY26 Financial ResultsJuly 23, 2025 | businesswire.comDr. Reddy’s to launch generic semaglutide in 87 countries: BloombergJuly 23, 2025 | msn.comDr. Reddy’s Laboratories (RDY) and Alvotech Enter Into a Collaboration and License AgreementJuly 23, 2025 | msn.comCerity Partners LLC Buys 88,628 Shares of Dr. Reddy's Laboratories Ltd (NYSE:RDY)July 20, 2025 | marketbeat.comCenterBook Partners LP Makes New Investment in Dr. Reddy's Laboratories Ltd (NYSE:RDY)July 19, 2025 | marketbeat.comDr. Reddy's Laboratories Ltd (NYSE:RDY) Shares Sold by Migdal Insurance & Financial Holdings Ltd.July 19, 2025 | marketbeat.comDr. Reddy's Laboratories (RDY) Expected to Announce Earnings on FridayJuly 18, 2025 | marketbeat.comDr. Reddy's Laboratories climbs Thursday, underperforms competitorsJuly 17, 2025 | marketwatch.comDr. Reddy’s Laboratories Ltd. (DRREDDY) Has a New Rating from Morgan StanleyJuly 16, 2025 | theglobeandmail.comSignaturefd LLC Cuts Stock Holdings in Dr. Reddy's Laboratories Ltd (NYSE:RDY)July 16, 2025 | marketbeat.comBallentine Partners LLC Lowers Stock Position in Dr. Reddy's Laboratories Ltd (NYSE:RDY)July 14, 2025 | marketbeat.comAllspring Global Investments Holdings LLC Sells 439,622 Shares of Dr. Reddy's Laboratories Ltd (NYSE:RDY)July 9, 2025 | marketbeat.comRDY - Dr Reddy's Laboratories Ltd ADR Valuation - MorningstarJuly 2, 2025 | morningstar.comMRDY Dr. Reddy's Laboratories Limited - Seeking AlphaJuly 2, 2025 | seekingalpha.comBessemer Group Inc. Purchases 81,024 Shares of Dr. Reddy's Laboratories Ltd (NYSE:RDY)June 27, 2025 | marketbeat.comDr. Reddy's Laboratories slips Thursday, underperforms competitorsJune 26, 2025 | marketwatch.comDr. Reddy's Laboratories Ltd (NYSE:RDY) Shares Sold by Robeco Institutional Asset Management B.V.June 26, 2025 | marketbeat.comDr. Reddy's Laboratories slips Monday, still outperforms marketJune 23, 2025 | marketwatch.comDr. Reddy's Laboratories Ltd (NYSE:RDY) Shares Sold by Ritholtz Wealth ManagementJune 19, 2025 | marketbeat.comGAMMA Investing LLC Purchases 66,049 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)June 17, 2025 | marketbeat.comRhumbline Advisers Sells 86,773 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)June 14, 2025 | marketbeat.comStanley Laman Group Ltd. Makes New $1.85 Million Investment in Dr. Reddy's Laboratories Limited (NYSE:RDY)June 13, 2025 | marketbeat.comDr. Reddy's Laboratories rallies Tuesday, outperforms competitorsJune 10, 2025 | marketwatch.comDr. Reddy's Laboratories Reaches Analyst Target PriceJune 8, 2025 | nasdaq.comHSBC Upgrades Dr. Reddy's Laboratories Limited - Depositary Receipt () (RDY)June 6, 2025 | msn.comDr. Reddy's Laboratories (NYSE:RDY) Upgraded by Hsbc Global Res to "Strong-Buy" RatingJune 6, 2025 | marketbeat.comHSBC Upgrades Dr. Reddy’s Laboratories Limited (RDY) to Buy from HoldJune 5, 2025 | msn.comDr. Reddy's Laboratories rallies Thursday, outperforms competitorsJune 5, 2025 | marketwatch.comHSBC upgrades Dr Reddy’s on weight loss drug semaglutide-driven earnings reboundJune 5, 2025 | in.investing.comDr. Reddy’s stock rises on biosimilar collaboration with AlvotechJune 5, 2025 | investing.comDr. Reddy's Laboratories (NYSE:RDY) Shares Gap Up - Time to Buy?June 5, 2025 | marketbeat.comDr. Reddy's Laboratories (NYSE:RDY) Raised to "Buy" at HSBCJune 5, 2025 | marketbeat.comAlvotech and Dr. Reddy's Enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda® (pembrolizumab)June 5, 2025 | businesswire.comAlvotech and Dr. Reddy’s Enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda® (pembrolizumab)June 5, 2025 | finance.yahoo.comAlvotech and Dr. Reddy’s partner to co-develop biosimilar candidate for Keytruda (pembrolizumab)June 5, 2025 | msn.comDr. Reddy’s Labs ADR Stock Price HistoryJune 4, 2025 | investing.comDr. Reddy's Laboratories rises Wednesday, underperforms marketJune 4, 2025 | marketwatch.comTwo Sigma Advisers LP Acquires 23,700 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)June 4, 2025 | marketbeat.comDr. Reddy's Laboratories slips Tuesday, outperforms competitorsJune 3, 2025 | marketwatch.comParallel Advisors LLC Sells 23,725 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)June 3, 2025 | marketbeat.com Get Dr. Reddy's Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for RDY and its competitors with MarketBeat's FREE daily newsletter. Email Address RDY Media Mentions By Week RDY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RDY News Sentiment▼1.150.38▲Average Medical News Sentiment RDY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RDY Articles This Week▼45▲RDY Articles Average Week Get Dr. Reddy's Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for RDY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Takeda Pharmaceutical News argenex News BeOne Medicines News BioNTech News Insmed News Summit Therapeutics News Teva Pharmaceutical Industries News Genmab A/S News Qiagen News Moderna News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:RDY) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr. Reddy's Laboratories Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Dr. Reddy's Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
